Evidence map›Paper›PMID 34050170›Full record

ArticleNature communications2021

Structure of the mature Rous sarcoma virus lattice reveals a role for IP6 in the formation of the capsid hexamer.

Martin Obr, Clifton L Ricana, Nadia Nikulin, Jon-Philip R Feathers, Marco Klanschnig, Andreas Thader, Marc C Johnson, Volker M Vogt, Florian K M Schur, Robert A Dick

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Retroviruses use different IPNature communications · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Structural insights into HIV-1 polyanion-dependent capsid lattice formation revealed by single particle cryo-EM.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Martin ObrInstitute of Science and Technology (IST) Austria, Klosterneuburg, Austria.
Clifton L RicanaDepartment of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, USA.ORCID http://orcid.org/0000-0002-9733-9136
Nadia NikulinDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.
Jon-Philip R FeathersDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.
Marco KlanschnigInstitute of Science and Technology (IST) Austria, Klosterneuburg, Austria.
Andreas ThaderInstitute of Science and Technology (IST) Austria, Klosterneuburg, Austria.
Marc C JohnsonDepartment of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, USA.
Volker M VogtDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.
Florian K M SchurInstitute of Science and Technology (IST) Austria, Klosterneuburg, Austria. florian.schur@ist.ac.at.ORCID http://orcid.org/0000-0003-4790-8078
Robert A DickDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA. rad82@cornell.edu.
Cornell University · USInstitute of Science and Technology Austria · ATUniversity of Missouri · US

Funding

GTPase Regulation of the Golgi Complex (Diversity Supplement 2023)R35GM136258 · NIGMS · CORNELL UNIVERSITY · PI J Christopher Fromme · 2020 to 2026
$4.0M
Retrovirus Structure and Assembly with Inositol PhosphatesR01AI147890 · NIAID · EMORY UNIVERSITY · PI DICK, ROBERT A · 2019 to 2022
$1.6M
Structure and Assembly of RetrovirusesR01AI150454 · NIAID · CORNELL UNIVERSITY · PI VOGT, VOLKER M. · 2019 to 2020
$719k
Examining the role of IP6 in HIV-1 replicationR21AI143363 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI JOHNSON, MARC C · 2019 to 2020
$418k
Austrian Science Fund FWF P 31445NIAID NIH HHS R01 AI147890NIAID NIH HHS R01 AI150454NIAID NIH HHS R21 AI143363NIGMS NIH HHS R35 GM136258
6 · The paper itself

Abstract

Inositol hexakisphosphate (IP6) is an assembly cofactor for HIV-1. We report here that IP6 is also used for assembly of Rous sarcoma virus (RSV), a retrovirus from a different genus. IP6 is ~100-fold more potent at promoting RSV mature capsid protein (CA) assembly than observed for HIV-1 and removal of IP6 in cells reduces infectivity by 100-fold. Here, visualized by cryo-electron tomography and subtomogram averaging, mature capsid-like particles show an IP6-like density in the CA hexamer, coordinated by rings of six lysines and six arginines. Phosphate and IP6 have opposing effects on CA in vitro assembly, inducing formation of T = 1 icosahedrons and tubes, respectively, implying that phosphate promotes pentamer and IP6 hexamer formation. Subtomogram averaging and classification optimized for analysis of pleomorphic retrovirus particles reveal that the heterogeneity of mature RSV CA polyhedrons results from an unexpected, intrinsic CA hexamer flexibility. In contrast, the CA pentamer forms rigid units organizing the local architecture. These different features of hexamers and pentamers determine the structural mechanism to form CA polyhedrons of variable shape in mature RSV particles.

Indexed as

Virus AssemblyCapsidCapsid ProteinsCryoelectron MicroscopyElectron Microscope TomographyGene Knockout TechniquesHEK293 CellsHumansModels, MolecularPhosphotransferases (Alcohol Group Acceptor)Phytic AcidProtein MultimerizationRecombinant ProteinsRous sarcoma virusSingle Molecule ImagingTransfectionCapsid Proteinsinositol 1,3,4,5,6-pentakisphosphate 2-kinasePhosphotransferases (Alcohol Group Acceptor)Phytic AcidRecombinant Proteins

Identifiers

PMID34050170
PMCPMC8163826
OpenAlexW3165609530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.